epilepsy_drug_qol_df

This dataset, epilepsy_drug_qol_df, is a data frame containing quality of life
measurements from the SANAD randomized controlled trial comparing carbamazepine
and lamotrigine in 544 epilepsy patients. QoL assessments were collected at
baseline, 3 months, 1 year and 2 years using validated instruments.

Offers a rich and diverse collection of datasets focused on the brain, nervous system, and related disorders.
The package includes clinical, experimental, neuroimaging, behavioral, cognitive, and simulated data on conditions such as
Parkinson's disease, Alzheimer's disease, dementia, epilepsy, schizophrenia, autism spectrum disorder, attention deficit, hyperactivity disorder,
Tourette's syndrome, traumatic brain injury, gliomas, migraines, headaches, sleep disorders, concussions, encephalitis,
subarachnoid hemorrhage, and mental health conditions. Datasets cover structural and functional brain data, cross-sectional and longitudinal
MRI imaging studies, neurotransmission, gene expression, cognitive performance, intelligence metrics, sleep deprivation effects, treatment outcomes,
brain-body relationships across species, neurological injury patterns, and acupuncture interventions. Data sources include peer-reviewed studies,
clinical trials, military health records, sports injury databases, and international comparative studies.
Designed for researchers, neuroscientists, clinicians, psychologists, data scientists, and students, this package facilitates exploratory data analysis,
statistical modeling, and hypothesis testing in neuroscience and neuroepidemiology.

Renzo Caceres Rossi

NeuroDataSets

A Comprehensive Collection of Neuroscience and Brain-Related
Datasets

epilepsy_drug_qol_df function

A data frame with 1,852 observations and 9 variables:<dl>
 <dt>id</dt>
<dd>Integer: Patient identification number</dd> <dt>with.time</dt>
<dd>Numeric: Time to withdrawal/discontinuation (days)</dd> <dt>trt</dt>
<dd>Factor with 2 levels: Treatment group (carbamazepine/lamotrigine)</dd> <dt>with.status</dt>
<dd>Integer: Withdrawal status indicator</dd> <dt>time</dt>
<dd>Numeric: Assessment time point (days since baseline)</dd> <dt>anxiety</dt>
<dd>Numeric: Anxiety score (from QoL measure)</dd> <dt>depress</dt>
<dd>Numeric: Depression score (from QoL measure)</dd> <dt>aep</dt>
<dd>Numeric: Adverse effects profile score</dd> <dt>with.status2</dt>
<dd>Numeric: Alternative withdrawal coding</dd>
</dl>

Format

SANAD Epilepsy Drug Treatment Quality of Life Study — epilepsy_drug_qol_df

A data frame with 1,852 observations and 9 variables:<dl>
 <dt>id</dt>
<dd>Integer: Patient identification number</dd>

 <dt>with.time</dt>
<dd>Numeric: Time to withdrawal/discontinuation (days)</dd>

 <dt>trt</dt>
<dd>Factor with 2 levels: Treatment group (carbamazepine/lamotrigine)</dd>

 <dt>with.status</dt>
<dd>Integer: Withdrawal status indicator</dd>

 <dt>time</dt>
<dd>Numeric: Assessment time point (days since baseline)</dd>

 <dt>anxiety</dt>
<dd>Numeric: Anxiety score (from QoL measure)</dd>

 <dt>depress</dt>
<dd>Numeric: Depression score (from QoL measure)</dd>

 <dt>aep</dt>
<dd>Numeric: Adverse effects profile score</dd>

 <dt>with.status2</dt>
<dd>Numeric: Alternative withdrawal coding</dd>


</dl>

epilepsy_drug_qol_df: SANAD Epilepsy Drug Treatment Quality of Life Study

Description

Usage

Arguments

Format

Details